GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study: Paris Thursday, February 13, 2025, 17: ...
Utthunga and VindAir to advance smart solutions for pharma and healthcare industries: Our Bureau, Bengaluru Thursday, February 13, 2025, 16:45 Hrs [IST] Utthunga, a leading provid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback